Jessica Terranova’s New Book ‘Wicker House’ is a Spellbinding Adventure About Dueling Witch Covens in the Dark and Magical Underbelly of New Orleans

Jessica Terranova’s New Book ‘Wicker House’ is a Spellbinding Adventure About Dueling Witch Covens in the Dark and Magical Underbelly of New Orleans

CHALMETTE, La. – October 25, 2022 – (Newswire.com)

Fulton Books author Jessica Terranova, a native Louisianian making her debut in the literary world, has completed her most recent book “Wicker House”: a gripping and potent story of witchcraft, self-discovery, rivalry, and family set in the heart of New Orleans.

“‘Wicker House’ follows seventeen-year-old orphan, Isabella, as she plans her life after the orphanage,” says author Jessica Terranova. “It was the only life she had ever known. How would she even be able to afford an apartment on a café-waitress salary? Walking past mansions and historic homes, her mind races, trying to think of her next move. Then two words above a door catch her eye: Wicker House.”

Published by Fulton Books, Jessica Terranova’s book takes readers on a captivating journey through the magical side of the Big Easy. When Isabella turns 18 and is forced to move out of the orphanage, she finds refuge in a nearby women’s shelter called Wicker House. But things are not always as they seem, and Isabella soon learns that Wicker House has a long-kept secret that she is inexplicably linked to. It is a coven of witches, and she is one of them.

According to Terranova, “living with a coven of witches is the last thing [Isabella] expected, let alone that she was part of their coven.” She must learn the truth about herself and the enchanted world around her, but as her strength continues to grow, so does the unwanted attention of the rival coven. Can Isabella learn to harness her powers while dark secrets threaten to crumble her new world?

Readers who wish to experience this mesmerizing work can purchase “Wicker House” at bookstores everywhere, or online at the Apple iTunes store, Amazon, Google Play, or Barnes & Noble.

Please direct all media inquiries to Author Support via email at [email protected] or via telephone at 877-210-0816.

Contact Information:

Media Relations

[email protected]

Press Release Service
by
Newswire.com

Original Source:

Jessica Terranova’s New Book ‘Wicker House’ is a Spellbinding Adventure About Dueling Witch Covens in the Dark and Magical Underbelly of New Orleans

Bernice Cohen’s New Book ‘Molly and Lee’s Awesome Adventures’ is a Thrilling Collection of Short Stories That Follow Two Siblings as They Experience Exciting Occurrences

Bernice Cohen’s New Book ‘Molly and Lee’s Awesome Adventures’ is a Thrilling Collection of Short Stories That Follow Two Siblings as They Experience Exciting Occurrences

SILVER SPRING, Md. – October 25, 2022 – (Newswire.com)

Fulton Books author Bernice Cohen, a retired nurse and Sunday school teacher, has completed her most recent book “Molly and Lee’s Awesome Adventures”: a charming and adorable collection of stories that follow Molly and Lee, two siblings, who find themselves encountering a myriad of adventures around the Jewish holidays that help them to explore the meaning of each special day.

“These stories will introduce you to a young brother and a sister and their adventures. Their names are Molly and Lee,” writes Cohen. “They are average Jewish children. They live with their parents and their big, fluffy dog in a house near your neighborhood. Their family goes to a synagogue similar to yours. Molly and Lee are not magical or super brains. They cannot fly or become invisible (although sometimes their schoolbooks disappear when it is time to catch the school bus), but they do have some very unusual experiences. Most of their adventures seem to take place around the time of Jewish holidays. I hope that you will enjoy reading these stories with or to your children.”

Published by Fulton Books, Bernice Cohen’s book is the perfect tool for young readers to be introduced to Jewish holidays and stories to help them appreciate cultures and religions different from their own. Full of vibrant artwork and imaginative journeys that Molly and Lee embark upon with the help of others, readers of all ages will find themselves spellbound and full of wonder as they follow along on Cohen’s exciting adventures.

Readers who wish to experience this engaging work can purchase “Molly and Lee’s Awesome Adventures” at select bookstores, or online at the Apple iTunes Store, Amazon, Google Play, or Barnes & Noble.

Please direct all media inquiries to Author Support via email at [email protected] or via telephone at 877-210-0816.

Contact Information:

Media Relations

[email protected]

Press Release Service
by
Newswire.com

Original Source:

Bernice Cohen’s New Book ‘Molly and Lee’s Awesome Adventures’ is a Thrilling Collection of Short Stories That Follow Two Siblings as They Experience Exciting Occurrences

The AcCELLerate Forum to Focus on Creating a Sustainable Ecosystem of Cell and Gene Therapy

The AcCELLerate Forum to Focus on Creating a Sustainable Ecosystem of Cell and Gene TherapyVirtual workshop on Nov. 17-18 bridges the gap between critical stakeholders to pinpoint today’s challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.

The AcCELLerate Forum to Focus on Creating a Sustainable Ecosystem of Cell and Gene Therapy
Be the Match

Be the Match

MINNEAPOLIS – October 24, 2022 – (Newswire.com)

The AcCELLerate Forum, a joint partnership between the American Society for Transplantation and Cellular Therapy (ASTCT™), the Center for International Blood and Marrow Transplant Research® (CIBMTR®), and the National Marrow Donor Program® (NMDP)/Be The Match®, brings key stakeholders together to identify ongoing needs and opportunities in cell and gene therapy for advocacy, measurement of value and impact and sustainability. The virtual workshop on Nov. 17-18, 2022, joins providers, payers, government agencies and industry members who will work together to define essential factors needed to create a sustainable cell and gene therapy ecosystem. 

“NMDP/Be The Match is proud to be one of the sponsors of this important forum that has interests for all key stakeholders across the ecosystem,” said Jeffery Auletta, M.D., Senior Vice President, Patient Outcomes and Experience, of NMDP/Be The Match, Chief Scientific Director, CIBMTR. “Our established relationships with a global network of transplant centers and cell and gene therapy developers uniquely position NMDP/Be The Match to bring these experts together to identify the needs and opportunities in this field for advocacy, measurement, and sustainability.”

Dr. Auletta will join industry and transplant center partners and other professionals to address the question, “Are Center-Specific Outcomes Possible for CAR T-cell Immunotherapy?” The participants will focus on the perspectives of the payer, data acquisition and analysis, and center perspectives in defining outcomes for CAR T cells. They will also discuss healthcare inequity, specifically barriers to access and their impact on cell therapy outcomes. The speakers will incorporate the evolving cell therapy landscape from industry collaboration to clinical trials and real-world treatment in their presentations and in a moderator-led roundtable with attendee participation. Visit the event website to register and see the complete schedule and list of presenters.

In addition to NMDP/Be The Match, the event co-hosts include:

The American Society for Transplantation and Cellular Therapy (ASTCT) is an international professional membership association of more than 3,000 physicians, investigators, and other health care professionals from more than 45 countries. Our mission is dedicated to improving the application and success of blood and marrow transplantation and related cellular therapies. For more information about ASTCT, visit www.astct.org and follow us on Twitter, @ASTCT.

The CIBMTR, a research collaboration between the NMDP/Be The Match and the Medical College of Wisconsin, facilitates critical cellular therapy research through a clinical database of more than 600,000 patients from more than 350 centers worldwide, with a biospecimen repository of more than 195,000 samples. 

Background:

The National Marrow Donor Program® (NMDP)/Be The Match® is the leading global partner working to save lives through cellular therapy. With 35 years of experience managing the most diverse registry of potential unrelated blood stem cell donors and cord blood units in the world, NMDP/Be The Match is a proven partner in providing cures to patients with life-threatening blood and marrow cancers and diseases. Through their global network, they connect centers and patients to their best cell therapy option—from blood stem cell transplant to a next-generation therapy—and collaborate with cell and gene therapy companies to support therapy development and delivery through Be The Match BioTherapies®. NMDP/Be The Match is a tireless advocate for the cell therapy community, working with hematologists/oncologists to remove barriers to consultation and treatment, and supporting patients through no-cost programs to eliminate non-medical obstacles to cell therapy. In addition, they are a global leader in research through the CIBMTR®—a collaboration with the Medical College of Wisconsin, investing in and managing research studies that improve patient outcomes and advance the future of care.

Contact Information:

Phyllis Grabot

[email protected]

Bonnie Quintanilla

[email protected]

Press Release Service
by
Newswire.com

Original Source:

The AcCELLerate Forum to Focus on Creating a Sustainable Ecosystem of Cell and Gene Therapy

Esophageal String Test®, a Less Invasive Way to Monitor Adults and Children With Eosinophilic Esophagitis (EoE), Launches in the US

Esophageal String Test®, a Less Invasive Way to Monitor Adults and Children With Eosinophilic Esophagitis (EoE), Launches in the USTest offers EoE patients a simple, clinically proven method to control their disease. “…Beyond thrilled to use this at Phoenix Children’s Hospital…” – Dr. Schroeder, Medical Director, Eosinophilic Disease Clinic, Phoenix Children’s Hospital

AURORA, Colo. – October 24, 2022 – (Newswire.com)

Clinicians with the Gastrointestinal Eosinophilic Disease Program at the Digestive Health Institute, Children’s Hospital of Colorado, performed the Esophageal String Test® (EST) on a patient in early September. The test will be offered regularly at the hospital.

The EST was also performed on patients in the Eosinophilic Gastrointestinal Disease Clinic at Phoenix Children’s Hospital. 

“I am now beyond thrilled to use this new esophageal surveillance technique at Phoenix Children’s and for my patients with eosinophilic gastrointestinal disorders. The EST is a game-changer for my patients who are looking for a less invasive and less expensive way to screen their disease activity,” said Dr. Shauna Schroeder, Medical Director for the Eosinophilic Gastrointestinal Disease Clinic at Phoenix Children’s Hospital. She further stated “Having trained in Denver, I had experience using the EST as a research tool in patients with eosinophilic esophagitis. I am now able to more granularly adjust medications and diets improving the care of my patients with eosinophilic esophagitis.”

The Esophageal String Test® utilizes a simple collection device, the EnteroTracker®, to collect upper gastrointestinal samples from adults and children.  The samples are sent to an independent reference lab for analysis of disease activity. Several other clinics around the country are planning to offer the test soon.

About EnteroTrack 

EnteroTrack, an early-stage company, develops simple-to-use, minimally invasive technologies to sample gastrointestinal (GI) mucosal content that can be assayed for various biomarkers of disease. The company’s platform technology, the EnteroTracker® is initially being used to support clinical monitoring of Eosinophilic Esophagitis in adults and children without need for sedation, advanced training, or complex procedures. Clinical studies evaluating the utility of the EnteroTracker® for additional applications including Esophageal Adenocarcinoma, Barrett’s Esophagus, GERD, GI microbiome, food allergy testing, and others are currently underway.

Contact Information:

Robin Shandas

CEO, Media and Investor Inquiries

[email protected]

Brookelynn Stillwell

General Inquiries

[email protected]

Press Release Service
by
Newswire.com

Original Source:

Esophageal String Test®, a Less Invasive Way to Monitor Adults and Children With Eosinophilic Esophagitis (EoE), Launches in the US